equitymaster.comFalseFalseSANDU PHARMA - Last 8 Quarters |
|
Interim Results |
| No. of Months
Qtr. Ending | 3
Mar-22* | 3
Jun-22* | 3
Sep-22* | 3
Dec-22* | 3
Mar-23* | 3
Jun-23* | 3
Sep-23* | 3
Dec-23* |
Net Sales | Rs m | 114 | 162 | 168 | 171 | 153 | 177 | 166 | 174 |
Other income | Rs m | 0 | 1 | 2 | 0 | 0 | 0 | 1 | 0 |
Turnover | Rs m | 115 | 163 | 169 | 171 | 153 | 177 | 167 | 175 |
Expenses | Rs m | 109 | 159 | 159 | 163 | 148 | 173 | 158 | 169 |
Gross profit | Rs m | 6 | 3 | 9 | 8 | 5 | 4 | 8 | 5 |
Depreciation | Rs m | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Interest | Rs m | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Profit before tax | Rs m | 4 | 3 | 9 | 7 | 4 | 2 | 8 | 4 |
Tax | Rs m | 2 | 1 | 3 | 2 | 1 | 1 | 2 | 2 |
Profit after tax | Rs m | 3 | 2 | 6 | 5 | 3 | 1 | 6 | 2 |
Gross profit margin | % | 5.0 | 2.0 | 5.1 | 4.8 | 3.2 | 2.0 | 5.0 | 2.9 |
Effective tax rate | % | 40.1 | 36.0 | 31.8 | 31.1 | 27.9 | 48.3 | 28.0 | 45.5 |
Net profit margin | % | 2.4 | 1.0 | 3.6 | 2.8 | 1.8 | 0.6 | 3.3 | 1.2 |
Diluted EPS | Rs | 0.3 | 0.2 | 0.6 | 0.5 | 0.3 | 0.1 | 0.6 | 0.2 |
Diluted EPS (TTM) | Rs | 1.6 | 1.4 | 1.5 | 1.6 | 1.6 | 1.5 | 1.5 | 1.2 |
* Results Consolidated | Source: Company Annual Reports, Regulatory Filings, Equitymaster |
Interim results exclude extraordinary / exceptional items |